TRPC1 and cyclic hematopoiesis: Finally, sildenafil, a phosphodiesterase-5 (PDE5) inhibitor currently used to treat PH, reduces TRPC1 expression, diminishing basal [Ca2+] and SOCE currents in PASMC and, consequently, the severity of PH in a CH rat model [75,80].